Skip to main content
. 2021 Sep 15;30(9):1243–1252. doi: 10.1089/jwh.2020.8807

FIG. 3.

FIG. 3.

Perceived cost burden of cervical cancer screening among MBMT-3 participants. This figure shows the distribution of perceived costs stemming from each of four components of cervical cancer screening. Screening costs were winsorized at the 95th percentile due to outliers. MBMT-3, MyBodyMyTest Phase Three.